Literature DB >> 23019135

Mouse models of growth hormone action and aging: a proteomic perspective.

Juan Ding1, Lucila Sackmann-Sala, John J Kopchick.   

Abstract

Growth hormone (GH) is a protein secreted by the anterior pituitary and circulates throughout the body to exert important actions on growth and metabolism. GH stimulates the secretion of insulin-like growth factor-I (IGF-I) that mediates some of the growth promoting actions of GH. The GH/IGF-I axis has recently been recognized as important in terms of longevity in organisms ranging from Caenorhabditis elegans to mice. For example, GH transgenic mice possess short lifespans while GH receptor null (GHR-/-) mice have extended longevity. Thus, the actions of GH (or IGF-I) or lack thereof impact the aging process. In this review, we summarize the proteomic analyses of plasma and white adipose tissue in these two mouse models of GH action, i.e. GH transgenic and GHR-/- mice. At the protein level, we wanted to establish novel plasma biomarkers of GH action as a function of age and to determine differences in adipose tissue depots. We have shown that these proteomic approaches have not only confirmed several known physiological actions of GH, but also resulted in novel protein biomarkers and targets that may be indicative of the aging process and/or new functions of GH. These results may generate new directions for GH and/or aging research.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019135      PMCID: PMC3756660          DOI: 10.1002/pmic.201200271

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  87 in total

Review 1.  Perspective: proteomics--see "spots" run.

Authors:  John J Kopchick; Edward O List; Douglas T Kohn; Gregory M O Keidan; Linghua Qiu; Shigeru Okada
Journal:  Endocrinology       Date:  2002-06       Impact factor: 4.736

2.  Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice.

Authors:  K J Snibson; P S Bhathal; T E Adams
Journal:  Liver       Date:  2001-04

Review 3.  Growth hormone and the heart.

Authors:  A Colao; P Marzullo; C Di Somma; G Lombardi
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

4.  Growth hormone increases inducible nitric oxide synthase expression in mesangial cells.

Authors:  Sonia Q Doi; Terry A Jacot; Donald F Sellitti; Przemyslaw Hirszel; Mario H Hirata; Gary E Striker; Liliane J Striker
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

Review 5.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Authors:  B L Wajchenberg
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

6.  Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse.

Authors:  S J Hauck; W S Hunter; N Danilovich; J J Kopchick; A Bartke
Journal:  Exp Biol Med (Maywood)       Date:  2001-06

7.  Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice.

Authors:  F P Dominici; G Arostegui Diaz; A Bartke; J J Kopchick; D Turyn
Journal:  J Endocrinol       Date:  2000-09       Impact factor: 4.286

8.  Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies.

Authors:  S Ogueta; I Olazabal; I Santos; E Delgado-Baeza; J P García-Ruiz
Journal:  J Endocrinol       Date:  2000-05       Impact factor: 4.286

9.  Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice.

Authors:  F Frick; M Bohlooly-Y; D Lindén; B Olsson; J Törnell; S Edén; J Oscarsson
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

10.  Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality.

Authors:  S J Hauck; A Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-04       Impact factor: 6.053

View more
  6 in total

1.  Growth hormone receptor signaling is dispensable for HSC function and aging.

Authors:  Morag H Stewart; Paula Gutierrez-Martinez; Isabel Beerman; Brian Garrison; Emily J Gallagher; Derek LeRoith; Derrick J Rossi
Journal:  Blood       Date:  2014-10-01       Impact factor: 22.113

2.  A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: potential impact of increased adiposity, leptin, and insulin with advancing age.

Authors:  Darlene E Berryman; Ellen R Lubbers; Vishakha Magon; Edward O List; John J Kopchick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-21       Impact factor: 6.053

3.  The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration.

Authors:  Edith Arnold; Stéphanie Thebault; German Baeza-Cruz; David Arredondo Zamarripa; Norma Adán; Andrés Quintanar-Stéphano; Miguel Condés-Lara; Gerardo Rojas-Piloni; Nadine Binart; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

4.  Insulin, IGF-1, and GH Receptors Are Altered in an Adipose Tissue Depot-Specific Manner in Male Mice With Modified GH Action.

Authors:  Rikke Hjortebjerg; Darlene E Berryman; Ross Comisford; Stuart J Frank; Edward O List; Mette Bjerre; Jan Frystyk; John J Kopchick
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

5.  Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence.

Authors:  Duc Tran; Johann Bergholz; Haibo Zhang; Hanbing He; Yang Wang; Yujun Zhang; Qintong Li; James L Kirkland; Zhi-Xiong Xiao
Journal:  Aging Cell       Date:  2014-04-30       Impact factor: 9.304

6.  The Long Intron 1 of Growth Hormone Gene from Reeves' Turtle (Chinemys reevesii) Correlates with Negatively Regulated GH Expression in Four Cell Lines.

Authors:  Wen-Sheng Liu; Jing-E Ma; Wei-Xia Li; Jin-Ge Zhang; Juan Wang; Qing-Hua Nie; Feng-Fang Qiu; Mei-Xia Fang; Fang Zeng; Xing Wang; Xi-Ran Lin; Li Zhang; Shao-Hao Chen; Xi-Quan Zhang
Journal:  Int J Mol Sci       Date:  2016-04-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.